comparemela.com
Home
Live Updates
Hong Kong Stock Exchange 1877 Hk - Breaking News
Pages:
3
4
5
6
7
8
9
Latest Breaking News On - Hong kong stock exchange 1877 hk - Page 2 : comparemela.com
Junshi Biosciences Announces Collaboration with Dr Reddy s
SHANGHAI, China, May 07, 2023 (GLOBE NEWSWIRE) Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) announced a.
New zealand
Andhra pradesh
United kingdom
United states
San francisco
South africa
Junshi biosciences
Junshi bioscience
Zhi li
Bombay stock exchange
Regulatory agency
Ir team
Reddy laboratories limited dr
Pr team
National stock exchange of india
Shanghai junshi biosciences co ltd
Junshi Biosciences Announces Phase 3 Clinical Study of
SHANGHAI, China, April 11, 2023 (GLOBE NEWSWIRE) Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading.
United states
San francisco
Hong kong
Zhi li
Junshi biosciences
Junshi bioscience
Ir team
Therapeutics inc
Drug administration
Global research
International federation of gynecology
Shanghai junshi biosciences co ltd
Pr team
Data monitoring committee
International federation
Independent data monitoring committee
Junshi Biosciences Announces Establishment of Joint Venture
The two parties will collaborate to develop and commercialize toripalimab in 9 Southeast Asian countries through a joint venture company, Excellmab .
United kingdom
United states
San francisco
Republic of
Hong kong
Junshi biosciences
Zhi li
Junshi bioscience
Drug administration
Pr team
Ir team
Stock exchange of hong kong
Shanghai junshi biosciences co ltd
Healthcare products regulatory agency
European medicines agency
National reimbursement drug list
Junshi Biosciences Announces Ongericimab (anti-PCSK9 mAb)
SHANGHAI, China, Feb. 27, 2023 (GLOBE NEWSWIRE) Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading.
United states
San francisco
Junshi bioscience
Junshi biosciences
Zhi li
Global research
Ir team
Second xiangya hospital of central south university
Cardiovascular health
Pr team
Shanghai junshi biosciences co ltd
Academician yaling
General hospital
Northern theatre
Professor shuiping
Second xiangya hospital
Junshi Biosciences Announces Toripalimab in Combination
SHANGHAI, China, Feb. 20, 2023 (GLOBE NEWSWIRE) Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) today announced.
United states
San francisco
Junshi bioscience
Junshi biosciences
Zhi li
Global research
Ir team
Drug administration
Data monitoring committee
National reimbursement drug list
European medicines agency
Pr team
Chinese people liberation army
Healthcare products regulatory agency
Chinese society of clinical oncology
Department of oncology
vimarsana © 2020. All Rights Reserved.